MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
60
Unique beneficiaries
—
Total services
61
Distinct HCPCS
2
Medicare payment
$3K
PRESCRIBING · PART D · 2024
Total Rx claims
266
Beneficiaries
—
Total drug cost
$36K
Distinct drugs
9
Brand share
31.6%
Top prescribed drugs
Estradiol107 claims
Clobetasol Propionate25 claims
Norethindrone Ac/Eth Estradiol19 claims
Valacyclovir Hcl19 claims
Estradiol18 claims
QUALITY · MIPS · 2024
Final MIPS score
93.9
Quality
85.0
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.80%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
REFERRAL NETWORK
Where Dina Dicenzo's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 3 outbound destinations.
Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| ALLE-KISKI MEDICAL CENTER | 39 | 115 |
| Quest Diagnostics Venture Llc Clinical Laboratory · Pittsburgh, PA | 20 | 38 |
| WEST PENN ALLEGHENY HEALTH SYSTEM INC | 16 | 40 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE